0000950170-23-070416.txt : 20231214
0000950170-23-070416.hdr.sgml : 20231214
20231214163008
ACCESSION NUMBER: 0000950170-23-070416
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231212
FILED AS OF DATE: 20231214
DATE AS OF CHANGE: 20231214
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Waltermire Robert E.
CENTRAL INDEX KEY: 0001876996
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33277
FILM NUMBER: 231487422
MAIL ADDRESS:
STREET 1: FOUR TOWER BRIDGE, 200 BARR HARBOR DRIVE
STREET 2: SUITE 200
CITY: WEST CONSHOHOCKEN
STATE: PA
ZIP: 19428
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MADRIGAL PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001157601
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 BARR HARBOR DRIVE, SUITE 400
CITY: WEST CONSHOHOCKEN
STATE: PA
ZIP: 19428
BUSINESS PHONE: 404-380-9263
MAIL ADDRESS:
STREET 1: 200 BARR HARBOR DRIVE, SUITE 400
CITY: WEST CONSHOHOCKEN
STATE: PA
ZIP: 19428
FORMER COMPANY:
FORMER CONFORMED NAME: SYNTA PHARMACEUTICALS CORP
DATE OF NAME CHANGE: 20010815
4
1
ownership.xml
4
X0508
4
2023-12-12
0001157601
MADRIGAL PHARMACEUTICALS, INC.
MDGL
0001876996
Waltermire Robert E.
C/O MADRIGAL PHARMACEUTICALS, INC.
200 BARR HARBOR DRIVE, SUITE 200
WEST CONSHOHOCKEN
PA
19428
false
true
false
false
Senior VP, Chief Pharma Dev.
false
Common Stock
2023-12-12
4
M
false
1300
87.92
A
6967
D
Common Stock
2023-12-12
4
S
false
500
216.00
D
6467
D
Common Stock
2023-12-12
4
S
false
800
219.00
D
5667
D
Common Stock
2023-12-13
4
M
false
2500
87.92
A
8167
D
Common Stock
2023-12-13
4
S
false
1500
225.00
D
6667
D
Common Stock
2023-12-13
4
S
false
1000
226.00
D
5667
D
Stock Option (Right to Buy)
87.92
2023-12-12
4
M
false
1300
0
D
2031-08-02
Common Stock
1300
23700
D
Stock Option (Right to Buy)
87.92
2023-12-13
4
M
false
2500
0
D
2031-08-02
Common Stock
2500
21200
D
All shares issued pursuant to the exercise of the options reported herein represent 3,800 shares underlying an overall option award of 35,000 shares. All exercised options had vested. As to the overall option for 35,000 shares, 25% of the shares underlying the option vested on August 2, 2022 and, thereafter, 6.25% of the shares vested, or will vest, on the last day of each successive three-month period, provided the Reporting Person continues in service with the Issuer on each such date.
*As attorney-in-fact for Reporting Person
/s/ Brian J. Lynch*
2023-12-14